PMID: 8969371Dec 1, 1996Paper

A profile of human immunodeficiency virus-infected adolescents receiving health care services at selected sites in the United States

The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
A S RogersL D'Angelo

Abstract

To determine the demographic/clinical profile of human immunodeficiency virus (HIV)-infected adolescents in care at selected sites. We mailed surveys requesting prevalence data from physicians in government-funded HIV research and care programs on HIV-infected youth (10-21 years) receiving care. A total of 49% responses yielded information on 978 subjects. Vertical, blood, and sexual were predominant transmission modes. Three-quarters were of an ethnic/racial minority; 50% were female. The earliest median CD4 count was 0.467 x 10(9)/liter (467/microliter). Percent asymptomatic varied by transmission: vertical (16%), blood products (40%), male-male sexual (67%) and female-male sexual (M:73%) (F:74%). Clinical indicated Pneumocystis carinii pneumonia prophylaxis was differentially prescribed: vertical (96%), blood (89%), and sexually (male-male-47%) (female-male: M: 36% and F: 56%). Of these youth 78% are not represented in national AIDS case data. Examination of numerator data from selected sites indicates three transmission-driven adolescent HIV epidemics with different characteristics. Minority youth are disproportionately represented; many vertically infected infants are surviving to adolescence; sexual activity is a signific...Continue Reading

References

Mar 1, 1992·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·S B Kinsman, G B Slap
Nov 1, 1991·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·A English
May 1, 1991·American Journal of Public Health·R L StricofL F Novick
Aug 1, 1990·American Journal of Public Health·R C HolmanB L Evatt
Nov 29, 1990·The New England Journal of Medicine·H D GayleJ W Curran
Jun 1, 1994·The Pediatric Infectious Disease Journal·M L LindegrenI Onorato
Mar 17, 1994·The New England Journal of Medicine·P S RosenbergJ J Goedert
Mar 17, 1993·JAMA : the Journal of the American Medical Association·T L ChengT G DeWitt
Jun 9, 1993·JAMA : the Journal of the American Medical Association·G A ConwayL R Petersen

❮ Previous
Next ❯

Citations

Apr 11, 2009·Current HIV/AIDS Reports·Hans M L Spiegel, Donna C Futterman
Nov 25, 2000·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·D A MurphyL R Muenz
Sep 1, 2001·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·D C FuttermanUNKNOWN Project ACCESSS Team of the Adolescent Medicine HIV/AIDS Research Network
Sep 1, 2001·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·A S Rogers
Apr 30, 1998·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·A S RogersS H Vermund
Aug 26, 1998·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·R E BradyK M Marconi
May 16, 2003·Seminars in Pediatric Infectious Diseases·Elizabeth R WoodsSion Kim Harris
Aug 10, 2000·AIDS Patient Care and STDs·G J HubaB Singer
Apr 21, 2001·AIDS Patient Care and STDs·G Remafedi
Nov 22, 2002·AIDS Patient Care and STDs·Elizabeth R WoodsUNKNOWN Boston HAPPENS Program Collaborators
Aug 6, 2010·Journal of Tropical Pediatrics·Maria Leticia Santos CruzUNKNOWN NISDI Pediatric Study Group 2010
Sep 24, 1999·Sexually Transmitted Diseases·A E MaxwellU S Warda
Mar 4, 2000·Pediatric Clinics of North America·D FuttermanN D Hoffman
May 9, 1998·Primary Care·S T LappaA B Moscicki
Oct 26, 2005·Journal of Interpersonal Violence·Henry D AnayaMary Jane Rotheram-Borus
Mar 21, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·M J Rotheram-BorusM A Etzel
Mar 26, 1999·Journal of Urban Health : Bulletin of the New York Academy of Medicine·R E ZambranaS C Scrimshaw
Dec 24, 1997·Pediatric Clinics of North America·S Lappa, A B Moscicki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.